#Japan #Tokyo #Transino #Medicated Mask #Brightening Facial

Transino Medicated Brightening Facial Mask: A New Era in Skincare

Daiichi Sankyo Healthcare Co., Ltd., based in Chuo-ku, Tokyo, is set to launch its renewed "Transino Medicated Brightening Facial Mask" on February 13, 2026. This beloved product from the comprehensive spot-care brand, Transino, signifies a major leap in skin whitening technology, integrating an improved formula and striking new packaging.

The revitalized Transino Medicated Brightening Facial Mask focuses particularly on skin damage caused by UV rays. It features "tranexamic acid," a potent active ingredient developed by Daiichi Sankyo, known for its effectiveness against skin disturbances, including melasma and other types of hyperpigmentation. The unique dual active ingredients persist, expertly targeting underlying causes of skin issues while tackling the effects of UV damage that compromise skin moisture and barrier function.

Key Features of the New Formula

• - Quick Rescue Care: Just 10 minutes on your skin brings a bright, radiant appearance.
• - Hydration Power: Each mask is infused with an equivalent of a month's worth of brightening essence.
• - Innovative Ingredient Boost: Adds new components like Aqua Veil, ensuring better adherence and an enhanced user experience.
• - Deep Penetration Technology: New infusion support ingredients ensure that the product penetrates the skin for lasting results, promoting firm, beautifully textured, and clear skin.

Development Insights

In recent years, sheet masks have become increasingly popular, especially among women aged 20 to 50, with one in two purchasing them regularly. The rise in demand has spurred the introduction of not only intensive treatment masks but also daily-use lotion-type products. The market for masks, including sheet formats, is anticipated to see substantial growth in 2023-2024, trending approximately 1.5 times higher than previous years. In this landscape, the Transino sheet mask is especially favored as a go-to solution for UV-damaged skin, making it a travel essential and a summertime staple.

Recognizing these demands, Daiichi Sankyo Healthcare has undertaken a comprehensive review of the formula and design aspects of the mask to ensure it exceeds user expectations.

About the Transino Brand

Founded by Daiichi Sankyo, the Transino brand centers around tranexamic acid, recognized for its targeted effects on melasma. The launch of the oral medication in 2007 marked the beginning of Transino's innovative approach to addressing skin troubles caused by hyperpigmentation in an over-the-counter product. Transino is now a holistic skincare brand addressing skin concerns both internally and externally, featuring a range of prescription and topical solutions.

Corporate Background

Daiichi Sankyo Healthcare operates under the guiding principle of meeting diverse medical needs through accessible OTC products. Expanding its business scope beyond pharmaceuticals, the company strives to offer functional skincare, oral care, and more, embodying its corporate motto "Fit for You - Your Partner for a Healthy Lifestyle." Through its initiatives, Daiichi Sankyo promotes self-care so everyone can maintain health and beauty, contributing to a healthier society.

For more details, visit Transino's official website or read the full press release here.